Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.41 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.34 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | SCN4A | P35499 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL976986 | 0.79 | BACE1 (0.46) | HSD11B1HSD11B2PIK3CGADORA2AADORA1 | |
| SCHEMBL1025471 | 0.75 | BACE1 (0.48) | HSD11B1HSD11B2 | |
| SCHEMBL1023748 | 0.75 | BACE1 (0.51) | HSD11B1HSD11B2PIK3CGSLC6A4SLC6A3 | |
| SCHEMBL978581 | 0.74 | BACE1 (0.50) | HSD11B1HSD11B2PIK3CGSLC6A4SLC6A3 | |
| SCHEMBL28636434 | 0.69 | HDAC6 (0.46) | — | |
| SCHEMBL9607818 | 0.69 | CSNK1A1 (0.44) | HSD11B1HSD11B2CYP2D6ADORA2AADORA1 | |
| SCHEMBL31544625 | 0.66 | CYP2D6 (0.57) | PIK3CGSMN1; SMN2HSP90AA1HSP90AB1HTR2B | |
| SCHEMBL3938440 | 0.66 | CYP2D6 (0.57) | PIK3CGSMN1; SMN2HSP90AA1HSP90AB1HTR2B | |
| SCHEMBL31463178 | 0.66 | CYP2D6 (0.57) | PIK3CGSMN1; SMN2HSP90AA1HSP90AB1HTR2B | |
| SCHEMBL9607809 | 0.65 | CSNK1A1 (0.43) | HSD11B1HSD11B2ADORA2AADORA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2451807-B1 | CYCLIC TRIAZO SODIUM CHANNEL BLOCKERS | UNIV GREENWICH (GB) | 2015-09-02 | — | — | EP | disclosed |
| US-8748600-B2 | Cyclic triazo sodium channel blockers | UNIVERSITY OF GREENWICH (GB) | 2014-06-10 | — | — | US | disclosed |
| US-8748600-B2 | Cyclic triazo sodium channel blockers | UNIVERSITY OF GREENWICH (GB) | 2014-06-10 | — | — | US | disclosed |
| US-20120135993-A1 | CYCLIC TRIAZO SODIUM CHANNEL BLOCKERS | UNIVERSITY OF GREENWICH (GB) | 2012-05-31 | — | — | US | disclosed |
| US-20120135993-A1 | CYCLIC TRIAZO SODIUM CHANNEL BLOCKERS | UNIVERSITY OF GREENWICH (GB) | 2012-05-31 | — | — | US | disclosed |
| WO-2011004196-A1 | CYCLIC TRIAZO SODIUM CHANNEL BLOCKERS | UNIVERSITY OF GREENWICH (GB) | 2011-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135993-A1 | CYCLIC TRIAZO SODIUM CHANNEL BLOCKERS | SCN1B, HCN3, SCN5A | HSD11B1 604/4885HSD11B2 618/4885PIK3CG 3241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.